James Hambro & Partners Thermo Fisher Scientific Inc. Transaction History

James Hambro & Partners

  • $2.64 Billion
  • Q4 2025

A detailed history of James Hambro & Partners transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, James Hambro & Partners holds 241,339 shares of TMO stock, worth $137 Million. This represents 5.18% of its overall portfolio holdings.

Number of Shares
241,339
Previous 249,732 3.36%
Holding current value
$137 Million
Previous $121 Million 13.0%
% of portfolio
5.18%
Previous 4.3%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026
SELL
$524.58 - $588.02 $4.4 Million - $4.94 Million
-8,393 Reduced 3.36%
241,339 $137 Million
Q3 2025

Oct 15, 2025
SELL
$404.94 - $499.99 $3.08 Million - $3.8 Million
-7,595 Reduced 2.95%
249,732 $121 Million
Q2 2025

Jul 17, 2025
BUY
$390.26 - $489.06 $8.94 Million - $11.2 Million
22,904 Added 9.77%
257,327 $104 Million
Q1 2025

Apr 17, 2025
BUY
$497.6 - $606.74 $6.08 Million - $7.41 Million
12,219 Added 5.5%
234,423 $117 Million
Q4 2024

Jan 22, 2025
BUY
$501.29 - $612.85 $6.39 Million - $7.81 Million
12,751 Added 6.09%
222,204 $116 Million
Q3 2024

Oct 21, 2024
BUY
$531.86 - $624.21 $6 Million - $7.04 Million
11,276 Added 5.69%
209,453 $130 Million
Q2 2024

Jul 16, 2024
BUY
$541.52 - $599.02 $2.82 Million - $3.12 Million
5,213 Added 2.7%
198,177 $110 Million
Q1 2024

Apr 26, 2024
BUY
$528.82 - $599.43 $2.68 Million - $3.04 Million
5,071 Added 2.7%
192,964 $112 Million
Q4 2023

Jan 19, 2024
BUY
$431.41 - $532.94 $7.16 Million - $8.84 Million
16,594 Added 9.69%
187,893 $99.7 Million
Q3 2023

Oct 24, 2023
BUY
$498.29 - $574.41 $6.94 Million - $8.01 Million
13,937 Added 8.86%
171,299 $86.7 Million
Q2 2023

Jul 20, 2023
BUY
$508.46 - $591.13 $4.17 Million - $4.84 Million
8,193 Added 5.49%
157,362 $82.1 Million
Q1 2023

Apr 21, 2023
BUY
$535.0 - $604.82 $1.55 Million - $1.75 Million
2,896 Added 1.98%
149,169 $86 Million
Q4 2022

Jan 25, 2023
BUY
$484.71 - $571.37 $270,952 - $319,395
559 Added 0.38%
146,273 $80.6 Million
Q3 2022

Oct 20, 2022
SELL
$507.19 - $604.49 $2.16 Million - $2.58 Million
-4,263 Reduced 2.84%
145,714 $74 Million
Q2 2022

Jul 22, 2022
SELL
$500.9 - $612.21 $34,562 - $42,242
-69 Reduced 0.05%
149,977 $81.5 Million
Q1 2022

May 05, 2022
BUY
$524.0 - $644.92 $94,844 - $116,730
181 Added 0.12%
150,046 $88.7 Million
Q4 2021

Feb 01, 2022
BUY
$569.0 - $667.24 $264,016 - $309,599
464 Added 0.31%
149,865 $100 Million
Q3 2021

Nov 05, 2021
BUY
$509.53 - $609.78 $4.01 Million - $4.8 Million
7,866 Added 5.56%
149,401 $85.3 Million
Q2 2021

Jul 20, 2021
BUY
$441.0 - $508.24 $4.54 Million - $5.23 Million
10,286 Added 7.84%
141,535 $71.4 Million
Q1 2021

Apr 28, 2021
BUY
$439.85 - $518.83 $5.24 Million - $6.18 Million
11,906 Added 9.98%
131,249 $59.9 Million
Q4 2020

Jan 14, 2021
BUY
$435.06 - $527.66 $4.07 Million - $4.93 Million
9,352 Added 8.5%
119,343 $55.6 Million
Q3 2020

Oct 13, 2020
BUY
$359.77 - $441.52 $31.9 Million - $39.2 Million
88,792 Added 418.85%
109,991 $48.5 Million
Q2 2020

Jul 13, 2020
BUY
$275.2 - $362.34 $5.28 Million - $6.96 Million
19,199 Added 959.95%
21,199 $7.67 Million
Q4 2018

Jan 17, 2019
SELL
$208.47 - $251.98 $417,565 - $504,715
-2,003 Reduced 50.04%
2,000 $447,000
Q2 2018

Jul 12, 2018
BUY
$203.14 - $219.53 $609 - $658
3 Added 0.08%
4,003 $829,000
Q4 2017

Feb 13, 2018
BUY
$182.03 - $200.37 $728,120 - $801,480
4,000
4,000 $760,000

Others Institutions Holding TMO

# of Institutions
2,952
Shares Held
334M
Call Options Held
4.14M
Put Options Held
3.54M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $222B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track James Hambro & Partners Portfolio

Follow James Hambro & Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Hambro & Partners, based on Form 13F filings with the SEC.

News

Stay updated on James Hambro & Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email